Sex: F
Vaccine: COVID19, FLUX
Symptoms: Asthma, Chest discomfort, Chest pain, Condition aggravated, Dyspnoea
Clinical narrative: out like five hours passed out; couldn't breathe; nor could talk; rash all over; chest was incredibly tight; chest was incredibly tight and they was hurting; Lips were blue; getting sicker; getting upper respiratory infection even worse; getting upper respiratory infection even worse; pain like her eyes were worst; bad allergic reaction to the vaccine; asthma is so much worst; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 14 year-old female patient received bnt162b2 (BNT162B2), administered in arm (Batch/Lot number: unknown) as dose 1, single and administered in arm (Lot number: EW0198, Expiration Date: 19Aug2021) as dose 2, single for covid-19 immunisation; influenza vaccine (FLU VACCINE) (Batch/Lot number: unknown) as dose number unknown, single for immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "some Allergies" (unspecified if ongoing); "upper respiratory infection" (unspecified if ongoing). Concomitant medication(s) included: ZOLOFT; PULMICORT FLEXHALER; NORETHINDRONE [NORETHISTERONE ACETATE] taken for oral contraception and unspecified medication (voice not clear). The following information was reported: LOSS OF CONSCIOUSNESS (life threatening), outcome "unknown", described as "out like five hours passed out"; DYSPNOEA (life threatening), outcome "not recovered", described as "couldn't breathe"; SPEECH DISORDER (life threatening), outcome "unknown", described as "nor could talk"; RASH (life threatening), outcome "unknown", described as "rash all over"; CHEST DISCOMFORT (life threatening), outcome "not recovered", described as "chest was incredibly tight"; CHEST PAIN (life threatening), outcome "not recovered", described as "chest was incredibly tight and they was hurting"; LIP DISCOLOURATION (life threatening), outcome "unknown", described as "Lips were blue"; ILLNESS (life threatening), outcome "unknown", described as "getting sicker"; UPPER RESPIRATORY TRACT INFECTION (life threatening), CONDITION AGGRAVATED (life threatening), outcome "unknown" and all described as "getting upper respiratory infection even worse"; EYE PAIN (life threatening), outcome "not recovered", described as "pain like her eyes were worst"; HYPERSENSITIVITY (life threatening), outcome "unknown", described as "bad allergic reaction to the vaccine"; ASTHMA (life threatening), outcome "unknown", described as "asthma is so much worst". Patient had both her vaccine at her doctor's office by Pfizer and she had horrible side effects to the point that she couldn't breathe, she had horrible rash all over her body, her chest was incredibly tight and they was hurting 'continuously', patient can't breathe, patient was out like five hours passed out 'like she was going away', her lips were blue and it's just horrible and she was completely ignored because in the papers were not coming out at that time. She couldn't breathe, neither she could breathe nor could talk. Her asthma was so much worst and she kept getting sicker, she kept getting upper respiratory infection even worse than she did before. The side effects that she had were life threatening and she could have died. She was still experiencing these pain like her eyes were worst, she can barely breathe some of time, fairly 'sucky'. She was pretty sure she had a really bad allergic reaction to the vaccine and then they still decided that it was okay to give her another vaccine anyway because there was nothing from Pfizer saying that they couldn't. Then there was trouble breathing, there was pain and pressure in her chest that never went away, she was completely out of it and her lips turned blue. First time she was 13 and second time she was 14th and the both time she almost died. She would just call her doctor's office. Therapeutic measures were not taken as a result of loss of consciousness, dyspnoea, speech disorder, rash, chest discomfort, chest pain, lip discolouration, illness, upper respiratory tract infection, condition aggravated, eye pain, hypersensitivity, asthma.  The lot number for bnt162b2 was not provided and will be requested during follow up.